Triple-negative breast cancer

Triple-negative breast cancer

Women with triple-negative breast cancer, and high levels of immune cells in the tumors, have a lower relapse risk after surgery, even without chemotherapy. This is shown by a study involving research at the University of Gothenburg.

Lower relapse risk in triple-negative breast cancer with high immune cell levels

According to recent research, women with triple-negative breast cancer who have high levels of immune cells in their tumors may experience a lower risk of relapse following surgery. This finding suggests that the immune system plays a crucial role in fighting against this type of cancer.